These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26431981)

  • 21. The Impact of Varying Numbers of Quadrivalent Human Papillomavirus Vaccine Doses on Anogenital Warts in the United States: A Database Study.
    Zeybek B; Lin YL; Kuo YF; Rodriguez AM
    J Low Genit Tract Dis; 2018 Jul; 22(3):189-194. PubMed ID: 29762430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiological impact of the human papillomavirus vaccination program on genital warts in Portugal: A retrospective, chart review study.
    Fernandes C; Alves J; Rodrigues A; Azevedo J;
    Vaccine; 2022 Jan; 40(2):275-281. PubMed ID: 34953608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease.
    Lacey CJ; Lowndes CM; Shah KV
    Vaccine; 2006 Aug; 24 Suppl 3():S3/35-41. PubMed ID: 16950016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination.
    Östensson E; Fröberg M; Leval A; Hellström AC; Bäcklund M; Zethraeus N; Andersson S
    PLoS One; 2015; 10(9):e0139062. PubMed ID: 26398189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence of genital warts in the Baltic countries: findings from national cross-sectional surveys in Estonia, Latvia and Lithuania.
    Uusküla A; Reile R; Rezeberga D; Karnite A; Logminiene Z; Padaiga Ž; Nygård M
    Sex Transm Infect; 2015 Feb; 91(1):55-60. PubMed ID: 25104496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.
    Ali H; Donovan B; Wand H; Read TR; Regan DG; Grulich AE; Fairley CK; Guy RJ
    BMJ; 2013 Apr; 346():f2032. PubMed ID: 23599298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-reported genital warts among sexually-active university students: a cross-sectional study.
    Cocchio S; Bertoncello C; Baldovin T; Buja A; Majori S; Baldo V
    BMC Infect Dis; 2018 Jan; 18(1):41. PubMed ID: 29334908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genital warts in men: a large population-based cross-sectional survey of Danish men.
    Munk C; Nielsen A; Liaw KL; Kjaer SK
    Sex Transm Infect; 2012 Dec; 88(8):640-4. PubMed ID: 22941865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of genital warts among U.S. service members before and after the introduction of the quadrivalent human papillomavirus vaccine.
    Nsouli-Maktabi H; Ludwig SL; Yerubandi UD; Gaydos JC
    MSMR; 2013 Feb; 20(2):17-20. PubMed ID: 23461306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of genital warts in adolescents and young adults in an integrated health care delivery system in the United States before human papillomavirus vaccine recommendations.
    Camenga DR; Dunne EF; Desai MM; Gee J; Markowitz LE; Desiliva A; Klein NP
    Sex Transm Dis; 2013 Jul; 40(7):534-8. PubMed ID: 23965766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decline in hospitalization for genital warts in the Veneto region after an HPV vaccination program: an observational study.
    Cocchio S; Baldovin T; Bertoncello C; Buja A; Furlan P; Saia M; Baldo V
    BMC Infect Dis; 2017 Apr; 17(1):249. PubMed ID: 28381294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus, genital warts, and vaccines.
    Hsueh PR
    J Microbiol Immunol Infect; 2009 Apr; 42(2):101-6. PubMed ID: 19597640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.
    Garland SM; Hernandez-Avila M; Wheeler CM; Perez G; Harper DM; Leodolter S; Tang GW; Ferris DG; Steben M; Bryan J; Taddeo FJ; Railkar R; Esser MT; Sings HL; Nelson M; Boslego J; Sattler C; Barr E; Koutsky LA;
    N Engl J Med; 2007 May; 356(19):1928-43. PubMed ID: 17494926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epidemiology of genital warts in female population of Czech Republic].
    Fait T; Dvořák V; Skřivánek A; Rokyta Z; Pilka R
    Ceska Gynekol; 2012 Aug; 77(4):360-3. PubMed ID: 23094779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
    Muñoz N; Manalastas R; Pitisuttithum P; Tresukosol D; Monsonego J; Ault K; Clavel C; Luna J; Myers E; Hood S; Bautista O; Bryan J; Taddeo FJ; Esser MT; Vuocolo S; Haupt RM; Barr E; Saah A
    Lancet; 2009 Jun; 373(9679):1949-57. PubMed ID: 19493565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme.
    Read TR; Hocking JS; Chen MY; Donovan B; Bradshaw CS; Fairley CK
    Sex Transm Infect; 2011 Dec; 87(7):544-7. PubMed ID: 21970896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The first vaccine against cancer: the human papillomavirus vaccine].
    Bősze P
    Orv Hetil; 2013 Apr; 154(16):603-18. PubMed ID: 23587540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Near elimination of genital warts in Australia predicted with extension of human papillomavirus vaccination to males.
    Korostil IA; Ali H; Guy RJ; Donovan B; Law MG; Regan DG
    Sex Transm Dis; 2013 Nov; 40(11):833-5. PubMed ID: 24113401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception?
    Licht AS; Murphy JM; Hyland AJ; Fix BV; Hawk LW; Mahoney MC
    Sex Transm Infect; 2010 Feb; 86(1):74-8. PubMed ID: 19841004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prophylactic role for the human papillomavirus quadrivalent vaccine in males.
    Yancey AM; Pitlick JM; Forinash AB
    Ann Pharmacother; 2010; 44(7-8):1314-8. PubMed ID: 20501891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.